Henry Schein EBITDA 2010-2024 | HSIC

Henry Schein EBITDA for the quarter ending June 30, 2024 was $0.233B, a 10.38% decline year-over-year.

  • Henry Schein 2023 EBITDA was 0.89B, a 7.19% decline from 2022.
  • Henry Schein 2022 EBITDA was 0.959B, a 9.7% decline from 2021.
  • Henry Schein 2021 EBITDA was 1.062B, a 47.3% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Henry Schein EBITDA 2010-2024 | HSIC

  • Henry Schein 2023 EBITDA was 0.89B, a 7.19% decline from 2022.
  • Henry Schein 2022 EBITDA was 0.959B, a 9.7% decline from 2021.
  • Henry Schein 2021 EBITDA was 1.062B, a 47.3% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.8B
McKesson (MCK)$66.6B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
West Pharmaceutical Services (WST)$21.5B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M